LichaoZhaoMD
Pathology • Oklahoma City, OKCytopathology, Anatomic Pathology, Clinical Pathology
Assistant Professor, Pathology (Clinical), University of Oklahoma College of Medicine
Are you Dr. Zhao?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 15 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
940 Stanton L. Young Blvd
Bms - 451
Oklahoma City, OK 73104Phone+1 405-271-1515Fax+1 405-271-1001- Is this information wrong?
Summary
- Dr. Lichao Zhao, MD is a board certified pathologist in Oklahoma City, Oklahoma. He is currently licensed to practice medicine in Oklahoma. He is affiliated with OU Medical Center Edmond and is an Assistant Professor at University of Oklahoma College of Medicine.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Cytopathology, 2010 - 2011
University of Oklahoma Health Sciences CenterResidency, Pathology-Anatomic and Clinical, 2006 - 2010
Tianjin Medical UniversityClass of 1991
Certifications & Licensure
OK State Medical License 2008 - 2024- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 2 citationsEndobronchial mucormycosis: A rare clinical entity diagnosed by endobronchial cryobiopsy.Awais Bajwa, Syed T Hussain, Houssein Youness, Ravi N Sawh, Lichao Zhao, Tony Abdo> ;Respiratory Medicine Case Reports. 2022 Jan 1
- 8 citationsUltrasound-Guided Fine-Needle Aspiration With Optional Core Needle Biopsy of Head and Neck Lymph Nodes and Masses: Comparison of Diagnostic Performance in Treated Squa...Jason M. Wagner, Natosha Monfore, Austin J. McCullough, Lichao Zhao, Rachel Conrad, Greg A. Krempl, Anthony M. Alleman> ;Journal of Ultrasound in Medicine. 2019 Sep 1
- 50 citationsAlternative splice variants of DCLK1 mark cancer stem cells, promote self‐renewal and drug‐resistance, and can be targeted to inhibit tumorigenesis in kidney cancerYang Ge, Nathaniel Weygant, Dongfeng Qu, Randal May, William L. Berry, Jiannan Yao, Parthasarathy Chandrakesan, Wei Zheng, Lichao Zhao, Karena L. Zhao, Michael Drake, ...> ;International Journal of Cancer. 2018 Sep 1
- Join now to see all
Hospital Affiliations
OU Medical Center EdmondEdmond, Oklahoma
